Heart Health
Better outcomes with generic statins
Image: Thinkstock |
They say you get what you pay for. But sometimes, paying less may lead to better results. People who were prescribed less-costly generic statins to lower their cholesterol levels were more likely to take their pills than people who were prescribed a brand-name statin, according to a study in the Sept. 15, 2014, Annals of Internal Medicine. The study compared data from nearly 84,000 people who started a generic statin with nearly 6,400 who started a brand-name drug. Those who took generic statins were also slightly less likely to be hospitalized for a serious heart problem or stroke or to die from any cause. The average copayment for a brand-name statin prescription was $48, compared with just $10 for generic statins. The cost factor may explain why people were more likely to take the medicine and therefore have better outcomes, the authors say.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.